Dr Phillips on the Safety and Efficacy of Glofitamab in Relapsed/Refractory MCL
Tycel Phillips, MD, MPH, discusses updated efficacy and safety data with glofitamab for the treatment of relapsed/refractory mantle cell lymphoma.
Source: onclive.com
Tycel Phillips News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Tycel Phillips. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Tycel Phillips Today - Breaking & Trending Today
Dr Phillips on the Rationale for the GLOBRYTE Trial in Relapsed/Refractory MCL
Tycel Phillips, MD, discusses the rationale for launching the phase 3 GLOBRYTE trial evaluating glofitamab monotherapy in patients with relapsed/refractory mantle cell lymphoma, highlighting ongoing enrollment efforts.
Source: onclive.com
Dr Phillips on the Evolving Treatment Landscape in MCL
Tycel Phillips, MD, discusses current and emerging therapeutic treatment strategies for patients with mantle cell lymphoma.
Source: onclive.com
Dr Phillips on the Use of Bispecific Antibodies and CAR T-Cell Therapy in MCL and FL
Tycel Phillips, MD, MPH, discusses the use of bispecific antibodies and CAR T-cell therapy across hematologic malignancies, including in patients with mantle cell lymphoma and follicular lymphoma.
Source: onclive.com
Dr Phillips on the Evaluation of Frontline Treatment With Acalabrutinib Plus BR in MCL
Tycel Phillips, MD, MPH, discusses the ongoing phase 3 ECHO trial of acalabrutinib plus bendamustine and rituximab in the front line for patients with mantle cell lymphoma.
Source: onclive.com